Skip to main content
. Author manuscript; available in PMC: 2023 Oct 31.
Published in final edited form as: J Thorac Cardiovasc Surg. 2022 Oct 8;165(3):828–839.e5. doi: 10.1016/j.jtcvs.2022.10.007

FIGURE 1.

FIGURE 1.

Study overview. A, Design. B, Protocol mandated timing of surgery in relationship to neoadjuvant therapy. aT4 due to mediastinal organ invasion and N3 disease were excluded. bMandatory: Driver mutations were removed. CT, Computed tomography; PET, positron emission tomography; SOC, standard of care; q3m, every 3 months; NSCLC, non–small cell lung cancer; C, cycle.